Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Harvard Bioscience (HBIO) over the last 15 years, with Q3 2025 value amounting to 1.02%.

  • Harvard Bioscience's Return on Invested Capital fell 9600.0% to 1.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.02%, marking a year-over-year decrease of 9600.0%. This contributed to the annual value of 0.06% for FY2024, which is 900.0% down from last year.
  • According to the latest figures from Q3 2025, Harvard Bioscience's Return on Invested Capital is 1.02%, which was down 9600.0% from 1.04% recorded in Q2 2025.
  • Over the past 5 years, Harvard Bioscience's Return on Invested Capital peaked at 0.08% during Q4 2021, and registered a low of 1.04% during Q2 2025.
  • Its 5-year average for Return on Invested Capital is 0.16%, with a median of 0.02% in 2024.
  • As far as peak fluctuations go, Harvard Bioscience's Return on Invested Capital surged by 900bps in 2021, and later tumbled by -9900bps in 2025.
  • Over the past 5 years, Harvard Bioscience's Return on Invested Capital (Quarter) stood at 0.08% in 2021, then plummeted by -182bps to 0.06% in 2022, then skyrocketed by 137bps to 0.02% in 2023, then plummeted by -381bps to 0.06% in 2024, then tumbled by -1485bps to 1.02% in 2025.
  • Its Return on Invested Capital was 1.02% in Q3 2025, compared to 1.04% in Q2 2025 and 0.71% in Q1 2025.